Vertex’s Orkambi Approved With Broad Label For Cystic Fibrosis
This article was originally published in The Pink Sheet Daily
Executive Summary
Quick launch is planned, with firm having prepared ‘at risk of having a successful approval’ – patient screening and reimbursement shepherding are early areas of focus.